Safety of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in patients with Parkinson's disease: preliminary results from the Phase 3 study dose titration phase Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Isaacson, S
  • Espay, A
  • Pahwa, R
  • Truong, D
  • Pappert, E
  • Gardzinski, P
  • Dzyngel, B
  • Agro, Albert
  • Fernandez, H
  • Hauser, R

publication date

  • May 1, 2017